<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03784118</url>
  </required_header>
  <id_info>
    <org_study_id>H1812-032-991</org_study_id>
    <nct_id>NCT03784118</nct_id>
  </id_info>
  <brief_title>Complications Associated With Arterial Line Placement in Children</brief_title>
  <official_title>Study on Complications After Arterial Line Placement and the Risk Factors in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find the risk factors for complications following arterial
      line catheterization. Ultrasonography is used to evaluate the size of artery which is
      cannulated, before and after catheterization. The complications include ischemia, bleeding,
      thrombosis and so on.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      artery observation with ultrasound
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of complications associated with arterial catheterization</measure>
    <time_frame>within 5 days after arterial catheterization</time_frame>
    <description>Number of participants with complications following arterial catheterization. The complications include thrombus, ischemia, oozing or bleeding, and color change, etc. If any of these occur, it is assumed that complications have occurred.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Age as a risk factor</measure>
    <time_frame>within 5 days after arterial catheterization</time_frame>
    <description>To evaluate the age as one of the risk factors for complications following arterial catheterization using univariable logistic regression analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of attempts as a risk factor</measure>
    <time_frame>within 5 days after arterial catheterization</time_frame>
    <description>To evaluate the number of attempts of arterial catheterization as one of the risk factors for complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of catheterization as a risk factor</measure>
    <time_frame>within 5 days after arterial catheterization</time_frame>
    <description>To evaluate the duration of catheterization as one of the risk factors for complications</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Complications After Arterial Catheterization</condition>
  <arm_group>
    <arm_group_label>Children</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children who are followed up after arterial catheterization for evaluation of complications, using ultrasonography</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasonography</intervention_name>
    <description>Ultrasonography is used to evaluate the change in artery size after arterial catheterization and to assess the complication in children</description>
    <arm_group_label>Children</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients under 5 years of age who require invasive arterial pressure
             monitoring

        Exclusion Criteria:

          -  Patients who do not need invasive arterial pressure monitoring
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee-Soo Kim Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hee-Soo Kim, PhD</last_name>
    <phone>82-2-2072-3659</phone>
    <email>dami0605@snu.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Soo Kim, MD, Ph.D</last_name>
      <phone>+82-2-2072-3661</phone>
      <email>dami0605@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Hee-Soo Kim, MD, MS</last_name>
      <phone>+821052878006</phone>
      <email>dami0605@snu.ac.kr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>December 11, 2018</study_first_submitted>
  <study_first_submitted_qc>December 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2018</study_first_posted>
  <last_update_submitted>March 5, 2019</last_update_submitted>
  <last_update_submitted_qc>March 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Soo Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

